Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
<h4>Background</h4>1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence...
Saved in:
| Main Authors: | Borna A Nyaoke, Gaudensia N Mutua, Rose Sajabi, Delvin Nyasani, Marianne W Mureithi, Omu A Anzala |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183788&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
by: Yunia Mayanja, et al.
Published: (2023-01-01) -
Impact of COVID-19 pandemic on the utilization of emergency medical services in Nairobi, Kenya
by: Maurine Mumo Mutua, et al.
Published: (2024-12-01) -
Systemic and Mucosal Concentrations of Nine Cytokines Among Individuals with Neisseria gonorrhoeae infection in Nairobi Kenya [version 2; peer review: 2 approved, 1 approved with reservations]
by: Marianne Mureithi, et al.
Published: (2023-10-01) -
Microbial contamination of herbs marketed to HIV-infected people in Nairobi (Kenya)
by: Lydia Kaume, et al.
Published: (2012-09-01) -
Vaginal microbiome dysbiosis and sexually transmitted infections correlate with concentrations of immunoglobulin isotypes in human cervicovaginal mucus: insights into HIV-1 transmission
by: Matrona M. Akiso, et al.
Published: (2025-07-01)